All Content Clinical Leader

  1. When Survival Comes First, Trials Come Last 8/1/2025

    Infectious disease PI Dr. Claudia Martorell has long focused on recruiting underserved populations into clinical trials. But amid healthcare cuts, economic instability, and a retreat from DEI initiatives, she’s now watching access unravel. In this interview, Martorell shares what happens when survival takes priority over research — and why diversity in trials is once again at risk.

  2. Why Are We So Afraid To Pay Research Participants? 8/1/2025

    Clinical researchers have long toiled over paying trial participants. Now, 1Day Sooner patient advocates explain why ethics and actual regulator sentiment should move industry to change its approach to participant payment.

  3. J&J Taps Tau-Based Diagnostics To Improve Alzheimer's Disease Trial Design And Enrollment 7/31/2025

    Johnson & Johnson's Fiona Elwood, Ph.D., discusses the potential of tau-based diagnostics to help design better trials and improve patient enrollment in Alzheimer's disease studies.

  4. Transforming Cardiac Monitoring In Biopharma With 6-Lead And 12-Lead Devices 7/30/2025

    Learn how you can monitor a large number of cardiac conditions in real-time and support clinical trials across phases and TAs.

  5. Transformative Cardiac Solutions 7/30/2025

    While traditional ECGs require on-site visits, delaying data and increasing drop-out risk, AliveCor''s FDA-Cleared ECG devices can be used on-site as well as in decentralized and fully remote trials.

  6. CDISC's New 360i Helps Move Trial Design From Manual To Modern 7/30/2025

    Take a deeper look into the CDISC 360i initiative by discovering 360i's benefits and learning how to get involved in its development and rollout.

  7. 5 Cs For Responding To FDA-483s — Strategies For Effective Compliance And Resolution 7/29/2025

    Former FDA Director of Bioresearch Monitoring Division (West) Eric Pittman, MBA, shares his top five tips for responding to FDA-483s.

  8. Introducing Arcinova, A Quotient Sciences Company 7/28/2025

    Arcinova offers solutions tailored for early development, from candidate selection through to proof of concept. This means faster, more efficient development pathways, deeper scientific expertise and expanded access to specialized services to help you bring innovative therapies to patients sooner.

  9. Age Restrictions In Clinical Trials Unjustly Harm Adults With Childhood Cancer 7/28/2025

    How old is too old for a pediatric cancer trial? Mom-turned-patient advocate Rosemary Sherrod argues that too-stringent age criteria wrongly exclude pediatric cancer patients as they approach adulthood.

  10. The 3 FDA Oncology Approvals That Will Have The Biggest Impact In 2025 7/25/2025

    The FDA wrapped up 2024 with 3 notable approvals. Harpreet Singh, MD and CMO, provides a recap.